INS and obesity disorder: Male NG2-ChR2 mice fed HFD for 16 weeks presented obesity, hyperglycemia, glucose intolerance, insulin resistance, defective glucose-stimulated insulin release (GSIS), and changes in islet gene expression such as Ins1, Ins2 and Gck (Figure S1).